“chris-garabedian” Archives

in
Entry Author Date Location
Ed Kaye on Sarepta’s Duchenne Quest, Rising to CEO & His New Startup 11/20/17 Boston
Landos Joins Garabedian’s Bio Startup Accelerator Xontogeny, Gets $10M 09/21/17 Boston
Going Big or Against the Tide: Meet the Big Idea & Contrarian Award Finalists 09/14/17 Boston
Ex-Sarepta CEO Garabedian Returns to Run Bio Accelerator Xontogeny 05/18/17 Boston
Near-Term FDA Nod Unlikely For Duchenne Drug After Negative Vote 04/25/16 Boston
Moving on From Sarepta, Krieg Lands at Cancer Startup Checkmate Pharma 08/12/15 Boston
BioMarin, Sarepta Update Positions In Race To Produce DMD Drug 06/29/15 San Francisco
East Coast Biotech Roundup: NY Bio Fund, Sarepta, ZappRx, & More 04/03/15 Boston
Garabedian’s Rocky Road at Sarepta Ends With Abrupt Resignation 04/01/15 Boston
More Drama for Sarepta as FDA Delays Duchenne Drug, Shares Tank 10/27/14 Boston
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Sarepta to Submit Application for Duchenne Drug, Shares Boom 04/21/14 Boston
Building Biotechs to Last: See the Agenda for Monday 12/05/13 San Francisco
Building Biotechs to Last: A Sneak Peek at the Agenda for Dec. 9 11/19/13 San Francisco
In Defense of Sarepta’s Chris Garabedian 11/14/13 National
Sarepta Shares Crumble As FDA Calls New Drug Application “Premature” 11/12/13 Boston
Building Biotechs to Last: See Bonnie Anderson, Dan Bradbury & More 11/07/13 Boston
Lessons from the St. Louis Cardinals and ‘Building Biotechs to Last’ 10/30/13 San Francisco
Paul Hastings, Adelene Perkins Join Xconomy Biotech Event Dec. 9 10/25/13 San Francisco
Profiles in Perseverance: Building Biotechs to Last. Coming Dec. 9 10/18/13 San Francisco
Join Xconomy for Profiles in Biotech Perseverance in SF Dec. 9 10/03/13 National
Sarepta to Seek FDA Approval For Duchenne Muscular Dystrophy Drug 07/24/13 Boston
Xconomy Boston’s Top 20 Stories of Q2 2013: Editor’s Picks 07/01/13 Boston
Profiles in Long-Termism: Sarepta Therapeutics CEO Chris Garabedian 06/10/13 National
Sarepta Drug Helps Boys With Duchenne to Walk; Shares Boom 10/03/12 Boston
Sarepta Moves From Seattle to Boston for the Talent 09/07/12 Seattle
Sarepta Holds Its Breath as Feds Order Halt to Ebola Work 08/07/12 Seattle
Sarepta’s Muscular Dystrophy Drug Improves With Time; Stock Booms 07/24/12 Seattle
AVI Biopharma Mulls Deal After Mixed Data With Muscular Dystrophy Drug 04/06/12 Seattle
AVI Biopharma Passes Small Study in Muscular Dystrophy 04/02/12 Seattle
Page 1 of 2 next page »